Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
Week In Review: $2.5 Billion In Deals Including LianBio's Initial $719 Million In In-Licensings
Article By:
ChinaBio® Today
Saturday, August 15, 2020 1:13 PM EDT
LianBio, a new Princeton-Shanghai company, acquired China rights to two BridgeBio oncology assets in a $531.5 million agreement. BridgeBio will receive $26.5 million in upfront payments, plus up to $505 million in future milestones.
Week In Review: Jiangsu's CTFH Signs $200 Million AI Drug Discovery Pact With Insilico
Article By:
ChinaBio® Today
Saturday, October 12, 2019 6:12 PM EDT
Jiangsu's CTFH Pharma formed a partnership worth up to $200 million with Insilico Medicine, which will use its AI technology to discover two triple-negative breast cancer candidates.
Week In Review: Hansoh Signs $1.5 Billion Cross-Border Deal For AI-Drug Discovery With Atomwise
Article By:
ChinaBio® Today
Saturday, September 14, 2019 4:53 PM EDT
China's Hansoh Pharma formed an AI-based small molecule drug discovery collaboration worth up to $1.5 billion with Atomwise of San Francisco.
Week In Review: Dalian Wanda Plans $10 Billion Chengdu Healthcare Park
Article By:
ChinaBio® Today
Saturday, April 15, 2017 3:10 PM EDT
Dalian Wanda Group, unveiled plans to invest $10bn in a Chengdu healthcare park. Plans call for the park to include two tier-one general hospitals, eight smaller specialized hospitals and 30 healthcare-related firms.